Nuvo Research, Paladin sign license agreement for Synera in Canada
Synera uses Nuvo’s Controlled Heat Assisted Drug Delivery (CHADD) technology. As per the terms of the agreements, Nuvo will receive a double digit royalty on net sales of
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.